Form 4 for BVS Bioventus Inc.
Accepted 2023-07-05 00:00:00 ET · period of report 2023-07-03 · accession 0001578563-23-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-07-03 | BVS | CHURCH KATRINA J | SVP, CCO | S - Sale | $2.83 | -394 | 11.8K | -3% | -$1,115 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-03 | S | D | 394 | $2.83 | 11,828 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.829 to $2.83, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. (F3) Includes 2,000 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4. |